Join to View Full Profile
1801 W Taylor StSuite 3DChicago, IL 60612
Phone+1 312-413-5569
Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2013 - 2017
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2010 - 2013
Saint Louis University School of MedicineClass of 2010
Certifications & Licensure
IL State Medical License 2017 - 2026
MA State Medical License 2014 - 2017
TX State Medical License 2012 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Management of Kidney Disease with Sickle Cell Disease.Momen Abbasi, Anand Srivastava, Santosh L Saraf
Journal of the American Society of Nephrology. 2025-06-26 - Associations of Proteinuria Trajectories with Kidney Failure and Death in Individuals with CKD.Avi G Aronov, Ashish Verma, Ana C Ricardo, Tanika N Kelly, Sushrut S Waikar
Kidney360. 2025-06-26 - Diabetes mellitus and APOL1 genotype increase the risk for chronic kidney disease progression in sickle cell disease.Ryan Sun, Anand Srivastava, Joseph L Zapater, Franklin Njoku, Jin Han
Blood. 2025-06-12
Press Mentions
GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II DiabetesNovember 13th, 2024- King George’s Medical University Patient Goes Home After Challenging TransplantJuly 14th, 2021
- Introducing Memory in Coarse-Grained Molecular SimulationsMay 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
